E. Koc Et Al. , "Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity," Drug Development and Industrial Pharmacy , vol.49, no.7, pp.467-478, 2023
Koc, E. Et Al. 2023. Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity. Drug Development and Industrial Pharmacy , vol.49, no.7 , 467-478.
Koc, E., Ciftci, F., Çalık, H., Korkmaz, S., & Koc, R., (2023). Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity. Drug Development and Industrial Pharmacy , vol.49, no.7, 467-478.
Koc, Erhan Et Al. "Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity," Drug Development and Industrial Pharmacy , vol.49, no.7, 467-478, 2023
Koc, Erhan Et Al. "Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity." Drug Development and Industrial Pharmacy , vol.49, no.7, pp.467-478, 2023
Koc, E. Et Al. (2023) . "Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity." Drug Development and Industrial Pharmacy , vol.49, no.7, pp.467-478.
@article{article, author={Erhan Koc Et Al. }, title={Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity}, journal={Drug Development and Industrial Pharmacy}, year=2023, pages={467-478} }